We have demonstrated that MAT1A expression in liver cancer cells can reduce cell proliferation, invasion of the cell model (through a decrease in the translation-related gene), and eukaryotic translation elongation (EEF1D), and that MAT1A expression can predict a better prognosis in human LIHC [13]. Here, MAT1A is linked to liver cancer.